Table 1 Characteristics of study population, exposure levels and biomarker levels at recruitment
All n = 6103 | Missing (n) | |
|---|---|---|
Age, years (mean, SD) | 57.5 (5.9) | 1 |
Sex (n (%)) | 0 | |
Men | 2572 (42%) | |
Women | 3531 (57%) | |
Alcohol, g (mean, SD) | 10.4 (12.5) | 323 |
Smoking status (n (%)) | 315 | |
Regular | 1347 (23%) | |
Occasional | 273 (5%) | |
Previous smoker | 1915 (33%) | |
Never smoker | 2253 (39%) | |
Number of cigarettes per day for regular and occasional smokers only (mean, SD) | 14 (9) | 185 |
Physical activity score (mean, SD) | 8137 (5923) | 366 |
Living alone vs with partner (n (%)) | 315 | |
Living alone | 1345 (23%) | |
With partner | 4443 (77%) | |
Country of birth (n (%)) | 314 | |
Sweden | 5125 (89%) | |
Outside of Sweden | 664 (12%) | |
Area Income 1994, Euro (mean, SD) | 13,830 (3047) | 33 |
Education (n (%)) | 322 | |
Low (< 9) | 2676 (47%) | |
Moderate | 1982 (34%) | |
High (> 12) | 1123 (19%) | |
Occupation (n (%)) | 355 | |
Blue collar | 2241 (39%) | |
White collar | 2906 (51%) | |
Others | 601 (11%) | |
Systolic blood pressure mmHg (mean, SD) | 141 (19) | 1 |
Diabetes (n (%)) | 0 | |
Yes | 293 (5%) | |
No | 5810 (95%) | |
CVD (n (%)) | 0 | |
Yes | 151 (2%) | |
No | 5951 (98%) | |
BMIa, kg/m2 (mean, SD) | 25.8 (4) | 8 |
Apo-B/Apo-A1 (mean, SD) | 0.7 (0.2) | 204 |
Statin use (n (%)) | 0 | |
Yes | 28 (0.5%) | |
No | 6075 (99.5%) | |
NSAID use (n (%)) | 0 | |
Yes | 63 (1%) | |
No | 6040 (99%) | |
Total PM10, μg/m3 (mean, SD) | 14.9 (1.7) | 46 |
Total PM2.5, μg/m3 (mean, SD) | 10.5 (0.8) | 46 |
Total PM coarse, μg/m3 (mean, SD) | 4.4 (1.1) | 46 |
Total NOx μg/m3 (mean, SD) | 39.1 (13.8) | 46 |
PM10 traffic, μg/m3 (mean, SD) | 2.8 (1.3) | 46 |
PM10 non-traffic, μg/m3 (mean SD) | 0.9 (0.2) | 46 |
Leukocytes, # cells × 109/L (median, p5 – p95) | 5.9 (3.9–9) | 18 |
NLR (median, p5 – p95)b | 2 (1.1–3.7) | 36 |
CRP, mg/L (median, p5 – p95)c | 1.4 (0.3–8.4) | 799 |
SuPAR, ng/ml (median, p5 – p95) | 2.8 (1.9–4.8) | 838 |
Lp-PLA2, ng/ml (median, p5 – p95) | 256 (157–415) | 710 |
Ceruloplasmin, g/L (median, p5 – p95) | 0.49 (0.35–0.73) | 1248 |
Orosomucoid, g/L (median, p5 – p95) | 0.7 (0.4–1.1) | 970 |
Haptoglobin, g/L (median, p5 – p95) | 1.3 (0.5–2.3) | 1412 |
C3, g/L (median, p5 – p95) | 1.51 (1.1–2.2) | 909 |
Alpha-1-antitrypsin, g/L (median, p5 – p95) | 1.2 (0.8–1.7) | 1005 |